Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins : an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins : an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration / B.A. Ference, C.P. Cannon, U. Landmesser, T.F. Lüscher, A.L. Catapano, K.K. Ray. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 39:27(2018 Jul 14), pp. 2540-2545. [10.1093/eurheartj/ehx450]